Related Experiment Video

Updated: Jun 17, 2026

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia
06:01

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia

Published on: August 18, 2015

[Mechanism underlying thrombus formation in cerebral infarction]

Kazuo Kitagawa1, Saburo Sakoda

  • 1Department of Neurology, Osaka University Graduate School of Medicine.

Rinsho Shinkeigaku = Clinical Neurology
|December 25, 2009
PubMed

Insights

Thrombus formation, influenced by blood flow, components, and vessels (Virchow's triad), requires anticoagulation for cardiogenic embolism and antiplatelet drugs for atherothrombotic stroke prevention.

Area of Science:

  • Cardiovascular Medicine
  • Hematology
  • Neurology

Context:

  • Virchow's triad identifies key factors in thrombus formation: blood flow, blood components, and blood vessels.
  • Cardiogenic embolism from atrial fibrillation involves fibrin-rich thrombus due to blood stagnation.
  • Atherothrombotic and lacunar infarction involve platelet-rich thrombus formation secondary to endothelial injury.

Purpose:

  • To differentiate the mechanisms of thrombus formation in cardiogenic embolism and atherothrombotic infarction.
  • To outline effective pharmacological strategies for preventing these thrombotic events.

Summary:

  • Anticoagulation is the primary treatment for preventing fibrin-rich thrombi in cardiogenic embolism associated with atrial fibrillation.
  • Antiplatelet agents like aspirin, clopidogrel, and cilostazol are crucial for preventing platelet-rich thrombi in atherothrombotic infarction and reducing stroke recurrence.
  • Statins offer adjunctive benefits by stabilizing plaques and improving endothelial function, further reducing ischemic stroke recurrence.

Impact:

  • Provides a clear distinction between two major types of thrombus formation and their respective preventative treatments.
  • Highlights the importance of targeted pharmacological interventions based on the underlying pathophysiology of thrombotic events.
  • Informs clinical practice regarding the optimal use of anticoagulants, antiplatelet drugs, and statins for stroke prevention.

More Related Videos

A Comprehensive Approach to Analyze the Cell Components of Cerebral Blood Clots06:12

A Comprehensive Approach to Analyze the Cell Components of Cerebral Blood Clots

Published on: July 21, 2023

A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model09:42

A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model

Published on: June 4, 2021

Related Concept Videos

Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
Ischemic Stroke l: Introduction01:15

Ischemic Stroke l: Introduction

Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...